{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:19:31Z","timestamp":1787008771602,"version":"build-2736575974"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,13]]},"abstract":"<jats:title>Lay Summary<\/jats:title>\n                  <jats:p>Glucagon-like peptide 1 agonists may reduce the risk of major adverse cardiovascular events, heart failure, and all-cause mortality among patients with multiple myeloma and Type 2 diabetes mellitus receiving proteasome inhibitors. The use of glucagon-like peptide 1 agonist is associated with a reduction in cardiovascular events and mortality among patients with multiple myeloma and Type 2 diabetes mellitus receiving proteasome inhibitors. The use of glucagon-like peptide 1 agonist is not associated with an increased risk of adverse events among patients with multiple myeloma and Type 2 diabetes mellitus receiving proteasome inhibitors.<\/jats:p>","DOI":"10.1093\/eurjpc\/zwaf017","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T06:29:27Z","timestamp":1737095367000},"page":"615-620","source":"Crossref","is-referenced-by-count":6,"title":["Cardiovascular outcomes and mortality in diabetic multiple myeloma patients initiated on proteasome inhibitors according to prior use of glucagon-like peptide 1 agonists"],"prefix":"10.1093","volume":"33","author":[{"given":"Yu-Cheng","family":"Chang","sequence":"first","affiliation":[{"name":"Department of Medicine, Danbury Hospital , Danbury, CT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yu","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Medicine, Danbury Hospital , Danbury, CT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0763-8157","authenticated-orcid":false,"given":"Kuan-Yu","family":"Chi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine , Bronx, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmin","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine , Bronx, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chang","sequence":"additional","affiliation":[{"name":"Section of Neurosurgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University , Tainan ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cho-Hung","family":"Chiang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital , Taipei ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Medicine, Danbury Hospital , Danbury, CT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5757-6161","authenticated-orcid":false,"given":"Cho-Han","family":"Chiang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mount Auburn Hospital, Harvard Medical School , 330 Mt Auburn St, Cambridge, MA 02138 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"2026031311375185300_zwaf017-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaccao.2022.12.005","article-title":"Cardiovascular toxicity of proteasome inhibitors: underlying mechanisms and management strategies: JACC: CardioOncology state-of-the-art review","volume":"5","author":"Georgiopoulos","year":"2023","journal-title":"JACC CardioOncol"},{"key":"2026031311375185300_zwaf017-B2","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1200\/JCO.19.00231","article-title":"Prospective study of cardiac events during proteasome inhibitor therapy for relapsed multiple myeloma","volume":"37","author":"Cornell","year":"2019","journal-title":"J Clin Oncol"},{"key":"2026031311375185300_zwaf017-B3","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/eurjpc\/zwad046","article-title":"Increased risk of cardiovascular disease associated with diabetes among adult cancer survivors: a population-based matched cohort study","volume":"30","author":"Oh","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"2026031311375185300_zwaf017-B4","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"2026031311375185300_zwaf017-B5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"2026031311375185300_zwaf017-B6","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N Engl J Med"},{"key":"2026031311375185300_zwaf017-B7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/eurjpc\/zwae379","article-title":"Albiglutide and atrial fibrillation in patients with Type 2 diabetes and established cardiovascular disease: insights from the Harmony Outcomes trial","volume":"33","author":"Krychtiuk","year":"2026","journal-title":"Eur J Prev Cardiol"},{"key":"2026031311375185300_zwaf017-B8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/ijms19010026","article-title":"Effects of glucagon-like peptide-1 on oxidative stress and Nrf2 signaling","volume":"19","author":"Oh","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2026031311375185300_zwaf017-B9","doi-asserted-by":"crossref","first-page":"ooad035","DOI":"10.1093\/jamiaopen\/ooad035","article-title":"A global federated real-world data and analytics platform for research","volume":"6","author":"Palchuk","year":"2023","journal-title":"JAMIA Open"},{"key":"2026031311375185300_zwaf017-B10","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1001\/jama.2023.19574","article-title":"Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss","volume":"330","author":"Sodhi","year":"2023","journal-title":"JAMA"},{"key":"2026031311375185300_zwaf017-B11","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/aje\/kwj149","article-title":"Variable selection for propensity score models","volume":"163","author":"Brookhart","year":"2006","journal-title":"Am J Epidemiol"},{"key":"2026031311375185300_zwaf017-B12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"2026031311375185300_zwaf017-B13","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"2026031311375185300_zwaf017-B14","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s40520-021-01805-2","article-title":"Charlson comorbidity index as a predictor of repeated hospital admission and mortality among older women diagnosed with cardiovascular disease","volume":"33","author":"Shebeshi","year":"2021","journal-title":"Aging Clin Exp Res"},{"key":"2026031311375185300_zwaf017-B15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.21037\/atm.2018.12.10","article-title":"Balance diagnostics after propensity score matching","volume":"7","author":"Zhang","year":"2019","journal-title":"Ann Transl Med"},{"key":"2026031311375185300_zwaf017-B16","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1177\/2047487320903638","article-title":"Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"27","author":"Pulipati","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"2026031311375185300_zwaf017-B17","doi-asserted-by":"crossref","first-page":"e2421305","DOI":"10.1001\/jamanetworkopen.2024.21305","article-title":"Glucagon-like peptide 1 receptor agonists and 13 obesity-associated cancers in patients with type 2 diabetes","volume":"7","author":"Wang","year":"2024","journal-title":"JAMA Netw Open"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwaf017\/61670695\/zwaf017.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/33\/4\/615\/61670695\/zwaf017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/33\/4\/615\/61670695\/zwaf017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:37:58Z","timestamp":1773416278000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/33\/4\/615\/7986654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":17,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,1,29]]},"published-print":{"date-parts":[[2026,3,13]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwaf017","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,1,29]]}}}